The walls of Foundation Medicine’s lounge are filled with photographs of patients who have benefited from the power of genomic profiling to alter the course of their cancer care. READ this informative article by Emmy and Peabody-Award winning journalist Pierre Valette, and learn about how Foundation Medicine is focused on bringing cutting-edge science and technology to everyday cancer care. The results speak for themselves. Of the 79,000 samples from cancer patients FMI tested in 2017, 38% percent were matched with an FDA approved therapy, 83% percent were matched with at least one relevant clinical trial, and all of them had at least one of those two outcomes. That is awesome!